ADAR1 Capital Management »

McKesson Corporation shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of McKesson Corporation (MCK) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in McKesson Corporation

Tip: Access up to 7 years of quarterly data

All positions including McKesson Corporation held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in McKesson Corporation by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $134k 250 536.85

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding McKesson Corporation

Vanguard Group
BlackRock
BlackRock
State Street Corporation
Massachusetts Financial Services
Jpmorgan Chase & Co
Geode Capital Management
T. Rowe Price Investment Management
Morgan Stanley
Franklin Resources
Bank of America Corporation
Royal Bank of Canada
Northern Trust
T. Rowe Price Associates
Arrowstreet Capital, Limited Partnership

View all funds holding McKesson Corporation